pembrolizumab
merck,neoimmunetech
['pembro', 'neoimmunetech']
in our poster discussion (#170) today at #asco we will reveal important data from our ongoing phase iia trial on how the combination of #nt-i7, a long-acting il-7, with #pembrolizumab show preliminary anticancer activity in diverse types of #coldtumours. we hope you will join us! 
NIT is a clinical-stage T cell-focused biotech company, dedicated to expand the horizon of Immuno-Oncology and infectious diseases